A citation-based method for searching scientific literature

Sahana Kumar, Anujan Ramesh, Ashish Kulkarni. Expert Opin Drug Discov 2020
Times Cited: 19







List of co-cited articles
138 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Targeting macrophages: therapeutic approaches in cancer.
Luca Cassetta, Jeffrey W Pollard. Nat Rev Drug Discov 2018
640
31


Macrophage biology in development, homeostasis and disease.
Thomas A Wynn, Ajay Chawla, Jeffrey W Pollard. Nature 2013
26


Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets.
Luca Cassetta, Stamatina Fragkogianni, Andrew H Sims, Agnieszka Swierczak, Lesley M Forrester, Hui Zhang, Daniel Y H Soong, Tiziana Cotechini, Pavana Anur, Elaine Y Lin,[...]. Cancer Cell 2019
341
26

TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy.
Christopher B Rodell, Sean P Arlauckas, Michael F Cuccarese, Christopher S Garris, Ran Li, Maaz S Ahmed, Rainer H Kohler, Mikael J Pittet, Ralph Weissleder. Nat Biomed Eng 2018
383
26

Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy.
Michael A Cannarile, Martin Weisser, Wolfgang Jacob, Anna-Maria Jegg, Carola H Ries, Dominik Rüttinger. J Immunother Cancer 2017
455
21

CSF-1R inhibition alters macrophage polarization and blocks glioma progression.
Stephanie M Pyonteck, Leila Akkari, Alberto J Schuhmacher, Robert L Bowman, Lisa Sevenich, Daniela F Quail, Oakley C Olson, Marsha L Quick, Jason T Huse, Virginia Teijeiro,[...]. Nat Med 2013
21

Tumor-associated macrophages: from mechanisms to therapy.
Roy Noy, Jeffrey W Pollard. Immunity 2014
21

Tumor-Associated Macrophages: Recent Insights and Therapies.
Jiawei Zhou, Ziwei Tang, Siyang Gao, Chunyu Li, Yiting Feng, Xikun Zhou. Front Oncol 2020
183
21

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis.
Bin-Zhi Qian, Jiufeng Li, Hui Zhang, Takanori Kitamura, Jinghang Zhang, Liam R Campion, Elizabeth A Kaiser, Linda A Snyder, Jeffrey W Pollard. Nature 2011
21

An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R Inhibitor, in Patients with Relapsed or Refractory Hodgkin Lymphoma.
Bastian von Tresckow, Franck Morschhauser, Vincent Ribrag, Max S Topp, Caly Chien, Shobha Seetharam, Regina Aquino, Sonja Kotoulek, Carla J de Boer, Andreas Engert. Clin Cancer Res 2015
71
21

M-1/M-2 macrophages and the Th1/Th2 paradigm.
C D Mills, K Kincaid, J M Alt, M J Heilman, A M Hill. J Immunol 2000
21

Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study.
Nicholas Butowski, Howard Colman, John F De Groot, Antonio M Omuro, Lakshmi Nayak, Patrick Y Wen, Timothy F Cloughesy, Adhirai Marimuthu, Sam Haidar, Arie Perry,[...]. Neuro Oncol 2016
285
21

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.
Stephen B Willingham, Jens-Peter Volkmer, Andrew J Gentles, Debashis Sahoo, Piero Dalerba, Siddhartha S Mitra, Jian Wang, Humberto Contreras-Trujillo, Robin Martin, Justin D Cohen,[...]. Proc Natl Acad Sci U S A 2012
848
21


The role of myeloid cells in cancer therapies.
Camilla Engblom, Christina Pfirschke, Mikael J Pittet. Nat Rev Cancer 2016
358
15

Monocyte and macrophage heterogeneity.
Siamon Gordon, Philip R Taylor. Nat Rev Immunol 2005
15

Tumour-associated macrophages as treatment targets in oncology.
Alberto Mantovani, Federica Marchesi, Alberto Malesci, Luigi Laghi, Paola Allavena. Nat Rev Clin Oncol 2017
15

Generation of monocyte-derived tumor-associated macrophages using tumor-conditioned media provides a novel method to study tumor-associated macrophages in vitro.
Brooke Benner, Luke Scarberry, Lorena P Suarez-Kelly, Megan C Duggan, Amanda R Campbell, Emily Smith, Gabriella Lapurga, Kallie Jiang, Jonathan P Butchar, Susheela Tridandapani,[...]. J Immunother Cancer 2019
60
15

LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment.
Changhao Chen, Wang He, Jian Huang, Bo Wang, Hui Li, Qingqing Cai, Feng Su, Junming Bi, Hongwei Liu, Bin Zhang,[...]. Nat Commun 2018
175
15



Targeting Tumor-Associated Macrophages in Cancer.
Paulina Pathria, Tiani L Louis, Judith A Varner. Trends Immunol 2019
373
15

Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy.
Russell Hughes, Bin-Zhi Qian, Charlotte Rowan, Munitta Muthana, Ioanna Keklikoglou, Oakley C Olson, Simon Tazzyman, Sarah Danson, Christina Addison, Mark Clemons,[...]. Cancer Res 2015
260
15

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial.
Timothy M Nywening, Andrea Wang-Gillam, Dominic E Sanford, Brian A Belt, Roheena Z Panni, Brian M Cusworth, Adetunji T Toriola, Rebecca K Nieman, Lori A Worley, Motoyo Yano,[...]. Lancet Oncol 2016
390
15


Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy.
Anujan Ramesh, Anthony Brouillard, Sahana Kumar, Dipika Nandi, Ashish Kulkarni. Biomaterials 2020
34
15

A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer.
Ashish Kulkarni, Vineethkrishna Chandrasekar, Siva Kumar Natarajan, Anujan Ramesh, Prithvi Pandey, Jayashree Nirgud, Harshangda Bhatnagar, Driti Ashok, Amrendra Kumar Ajay, Shiladitya Sengupta. Nat Biomed Eng 2018
86
15

First-in-Human Study of AMG 820, a Monoclonal Anti-Colony-Stimulating Factor 1 Receptor Antibody, in Patients with Advanced Solid Tumors.
Kyriakos P Papadopoulos, Larry Gluck, Lainie P Martin, Anthony J Olszanski, Anthony W Tolcher, Gataree Ngarmchamnanrith, Erik Rasmussen, Benny M Amore, Dirk Nagorsen, John S Hill,[...]. Clin Cancer Res 2017
103
15

Tumor-associated macrophages: an accomplice in solid tumor progression.
Yibing Chen, Yucen Song, Wei Du, Longlong Gong, Haocai Chang, Zhengzhi Zou. J Biomed Sci 2019
290
15

Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy.
Xiang Zheng, Kati Turkowski, Javier Mora, Bernhard Brüne, Werner Seeger, Andreas Weigert, Rajkumar Savai. Oncotarget 2017
149
15

PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity.
Sydney R Gordon, Roy L Maute, Ben W Dulken, Gregor Hutter, Benson M George, Melissa N McCracken, Rohit Gupta, Jonathan M Tsai, Rahul Sinha, Daniel Corey,[...]. Nature 2017
919
15

Macrophages and Metabolism in the Tumor Microenvironment.
Ilio Vitale, Gwenola Manic, Lisa M Coussens, Guido Kroemer, Lorenzo Galluzzi. Cell Metab 2019
408
15

Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.
William D Tap, Zev A Wainberg, Stephen P Anthony, Prabha N Ibrahim, Chao Zhang, John H Healey, Bartosz Chmielowski, Arthur P Staddon, Allen Lee Cohn, Geoffrey I Shapiro,[...]. N Engl J Med 2015
287
15

Coordinated regulation of myeloid cells by tumours.
Dmitry I Gabrilovich, Suzanne Ostrand-Rosenberg, Vincenzo Bronte. Nat Rev Immunol 2012
10


Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity.
Hui-Ming Chen, William van der Touw, Yuan Shuo Wang, Kyeongah Kang, Sunny Mai, Jilu Zhang, Dayanira Alsina-Beauchamp, James A Duty, Sathish Kumar Mungamuri, Bin Zhang,[...]. J Clin Invest 2018
72
10

Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response.
Eric Ubil, Laura Caskey, Alisha Holtzhausen, Debra Hunter, Charlotte Story, H Shelton Earp. J Clin Invest 2018
71
10

Macrophages in tumor microenvironments and the progression of tumors.
Ning-Bo Hao, Mu-Han Lü, Ya-Han Fan, Ya-Ling Cao, Zhi-Ren Zhang, Shi-Ming Yang. Clin Dev Immunol 2012
558
10

The polarization of immune cells in the tumour environment by TGFbeta.
Richard A Flavell, Shomyseh Sanjabi, Stephen H Wrzesinski, Paula Licona-Limón. Nat Rev Immunol 2010
605
10

Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy.
Amira A Barkal, Kipp Weiskopf, Kevin S Kao, Sydney R Gordon, Benyamin Rosental, Ying Y Yiu, Benson M George, Maxim Markovic, Nan G Ring, Jonathan M Tsai,[...]. Nat Immunol 2018
199
10

Development of monocytes, macrophages, and dendritic cells.
Frederic Geissmann, Markus G Manz, Steffen Jung, Michael H Sieweke, Miriam Merad, Klaus Ley. Science 2010
10

TTI-621 (SIRPαFc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding.
Penka S Petrova, Natasja Nielsen Viller, Mark Wong, Xinli Pang, Gloria H Y Lin, Karen Dodge, Vien Chai, Hui Chen, Vivian Lee, Violetta House,[...]. Clin Cancer Res 2017
155
10

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.
David G DeNardo, Donal J Brennan, Elton Rexhepaj, Brian Ruffell, Stephen L Shiao, Stephen F Madden, William M Gallagher, Nikhil Wadhwani, Scott D Keil, Sharfaa A Junaid,[...]. Cancer Discov 2011
10

Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy.
Takami Sato, Mizue Terai, Yutaka Tamura, Vitali Alexeev, Michael J Mastrangelo, Senthamil R Selvan. Immunol Res 2011
163
10

Biology and therapeutic targeting of tumour-associated macrophages.
Tim Beltraminelli, Michele De Palma. J Pathol 2020
41
10

PI3Kγ is a molecular switch that controls immune suppression.
Megan M Kaneda, Karen S Messer, Natacha Ralainirina, Hongying Li, Christopher J Leem, Sara Gorjestani, Gyunghwi Woo, Abraham V Nguyen, Camila C Figueiredo, Philippe Foubert,[...]. Nature 2016
617
10

Microenvironmental regulation of tumor progression and metastasis.
Daniela F Quail, Johanna A Joyce. Nat Med 2013
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.